Erythrocyte PIG‐A mutant frequencies in cancer patients receiving cisplatin

Erythrocyte PIG‐A mutant frequencies in cancer patients receiving cisplatin

Abstract Background Cisplatin is a primary chemotherapy choice for various solid tumors. DNA damage caused by cisplatin results in apoptosis of tumor cells. Cisplatin‐induced DNA damage, however, may also result in mutations in normal cells and the initiation of secondary malignancies. In the curren...

Full description

Bibliographic Details
Main Authors: Vasily N. Dobrovolsky, Omar T. Atiq, Robert H. Heflich, Mackean Maisha, Page B. McKinzie, Mason G. Pearce, Timothy W. Robison
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Cancer Medicine
Subjects:
chemotherapy
erythrocytes
head and neck cancer (HNC)
mutations
Phosphatidylinositol glycan class‐A (PIG‐A) gene
Online Access:https://doi.org/10.1002/cam4.6895

Similar Items

Similar Items